Goldman Sachs
HCAT icon

Goldman Sachs’s Health Catalyst HCAT Stock Holding History

Goldman Sachs’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37,200
Closed -$1.36M – 5571
2020
Q3 		$1.36M Hold
37,200
– – ﹤0.01% 3857
2020
Q2 		$1.08M Hold
37,200
– – ﹤0.01% 3891
2020
Q1 		$973K Buy
+37,200
New +$1.14M ﹤0.01% 3784

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's HCAT Position: Q2 2026 in Review

Goldman Sachs increased its Health Catalyst (HCAT) stake by 24% in Q2 2026, buying an estimated $135K and bringing the position to 480,970 shares worth $957K. The position accounts for ﹤0.01% of the portfolio, ranked #5248.

Goldman Sachs first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $20.7M in Q2 2022. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Goldman Sachs held 480,970 shares of Health Catalyst worth $957K as of Q2 2026.
  • Goldman Sachs bought 93,798 Health Catalyst shares in Q2 2026, an estimated $135K.
  • Health Catalyst made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5248 holding.
  • Goldman Sachs first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Goldman Sachs's Health Catalyst position peaked at $20.7M in Q2 2022.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.